[ Drug name ] "Qinghong" pancreatic kininogenase enteric-coated tablet

                         Pancreatic Kinionogenase Enteric-coated Tab.

                         Pinyin: Yijitaiyuanmei Changrong Pian

【composition】

The main ingredient of this product is pancreatic kininogenase

【 properties   】

This product is an enteric-soluble garment tablet. It appears white or light brown after removing the coating.

  [  Appetite  ]

A vasodilator.It has the effect of improving microcirculation.Mainly used for microcirculation disorders, such as diabetes caused by nephropathy, retinopathy, peripheral neuropathy, fundus disease and ischemic cerebrovascular disease, can also be used for the adjuvant treatment of hypertension

【 specification 】

600,000 units *60 pieces/box, 300 boxes/piece.

[Usage and dosage]

Oral administration, 120-240 units (2-4 tablets), three times a day, on an empty stomach.

[Adverse Reactions]

Occasionally skin rash, skin itching and other allergic phenomena, stomach discomfort and tiredness and other feelings, disappeared after stopping the drug.

【 taboo 】

Intracerebral hemorrhage and other hemorrhagic diseases are prohibited in the acute phase.

[  Precautions  ]

This product is an enteric coated garment tablet and should be swallowed whole to prevent the drug from being destroyed in the stomach.

[   Medication for pregnant and lactating women   ]

This experiment was not conducted and no reliable references were available.

[  Children's medicine  ]

This experiment was not conducted and no reliable references were available.

[  Medication for the elderly  ]

This experiment was not conducted and no reliable references were available.

[  Drug interactions  ]

1. This product and protease inhibitor cannot be used at the same time.

2. This product has synergistic effect with angiotensin converting enzyme inhibitor (ACEI).

[  Drug overdose  ]

This experiment was not conducted and no reliable references were available.

2. Pharmacological toxicology

It can dilate blood vessels and improve microcirculation.Activate fibrinolytic enzyme, reduce blood viscosity;Activate phospholipase A2, prevent platelet aggregation, prevent thrombosis, etc.

[  Pharmacokinetics  ]

The plasma concentration reached peak at 4 h after oral administration, T1 /27 h, and was mainly excreted via the kidney.

【 storage 】

Seal and store in a cool place (no more than 20 ° C).

【 packing 】

Medical PVC hard sheet, medical PTP aluminum foil, 20 pieces/board X3 board/box.

[Effective period]

24 months

[Implementation standard]

WS1-XG-004-2006

[Approval Number]

National medicine approval H19993610

[Manufacturer]

Chengdu Tongde Pharmaceutical Co. Ltd

[Retail Price]

600,000 units *60 pieces/box, 48.1 yuan.

[Product Category]

Heart head blood-vessel

Product features:

This product is enteric soluble preparation, not destroyed by gastric acid and digestive enzymes, easy to absorb, improve the bioavailability.This product is a national medical insurance product;Prevention and treatment of diabetic complications of the first choice of medication;The products have good academic foundation and high clinical recognition.

Product advantages:

1. Exact curative effect: unique mechanism of action, dilate arterioles and capillaries, improve microcirculation and prevent thrombosis and vascular sclerosis.

2. Advanced production technology: raw materials are processed by modern biotechnology, with high purity and strong activity.The preparation is produced by film coating technology, and the dissolution and stability are significantly better than that of sugar coating technology, which is beneficial to long-term use of diabetes patients.

3, good safety: biochemical preparation, less side effects, no serious adverse reactions have been reported, suitable for long-term clinical use,

4, good price: reasonable price, good quality.

Can support: 1, strict market protection to create an orderly market environment, regional exclusive agent, so that your agent will not be because of the string of goods and the interests of damage, the enterprise will continue to give agents to do comprehensive service work;

2. Provide legal operation procedures, low base price and large space so that you can get rich returns, establish long-term cooperation, increase the confidence of product cooperation;

3, Newspaper, exhibition, network and other comprehensive publicity to enable you to quickly open the market;

4, Exquisite gifts and promotional materials, perfect after-sales tracking, let you feel the large pharmaceutical companies meticulous and thoughtful service, complete the task of year-end rebate;

5. The terminal staff of the manufacturer assisted in market maintenance.

6. Timely delivery, high quality products, follow-up products, preferential prices, regional market planning, market protection, technical training, academic support.

Requirements for agents: a mature and perfect sales network;

Have a strong sense of responsibility and confidence;

Unobstructed market channels;

Perfect sales network;

Good business network reputation;

Have a certain economic strength and good business reputation;

Have rich experience in market operation, strong market development ability;

Companies and individuals with terminal (OTC, RX) promotion ability;

1. Strictly sign agency agreement.

2. Periodic assessment and communication, identifying problems and solving them;

3, can do clinical, but also can do OTC promotion and downward distribution.

Province of investment attraction: the whole country